Beam Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 64 U.S.-traded ETFs. BEAM has around 16.4M shares in the U.S. ETF market. The largest ETF holder of BEAM is the ARK Innovation ETF (ARKK), with approximately 6.82M shares. Investors may also find of interest that the ETF with the largest allocation to BEAM stock is Direxion Nanotechnology ETF (TYNE), with a portfolio weight of 20.53%. On average, U.S. ETFs allocate 1.12% of BEAM to their portfolios.
Additionally, BEAM is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BEAM as a holding is the Avantis U.S. Equity ETF (AVUS), with a return of --.